Overview Financials News + Filings Key Docs Charts Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Quarterly results Appointed director CC transcript
|
BIOCRYST PHARMACEUTICALS INC (BCRX)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
02/14/2023 |
SC 13G/A
| BAKER BROS. ADVISORS LP reports a 10% stake in BioCryst Pharmaceuticals, Inc. |
02/06/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/03/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/14/2022 |
SC 13G/A
| BAKER BROS. ADVISORS LP reports a 10% stake in BioCryst Pharmaceuticals, Inc. |
02/09/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/09/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/01/2022 |
SC 13G/A
| BlackRock Inc. reports a 8.2% stake in BIOCRYST PHARMACEUTICALS INC |
04/12/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/16/2021 |
SC 13G/A
| BAKER BROS. ADVISORS LP reports a 10% stake in BioCryst Pharmaceuticals, Inc. |
02/16/2021 |
SC 13G/A
| CITADEL ADVISORS LLC reports a 3.8% stake in * BioCryst Pharmaceuticals, Inc. |
02/16/2021 |
SC 13G/A
| Point72 Asset Management, L.P. reports a 2.1% stake in BIOCRYST PHARMACEUTICALS, INC. |
02/11/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/10/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/10/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
12/10/2020 |
SC 13G/A
| STATE STREET CORP reports a 10.2% stake in AMENDED FILING BioCryst Pharmaceuticals Inc |
02/14/2020 |
SC 13G/A
| Point72 Asset Management, L.P. reports a 5.4% stake in BIOCRYST PHARMACEUTICALS, INC. |
02/14/2020 |
SC 13G/A
| RA CAPITAL MANAGEMENT, LLC reports a 0% stake in BIOCRYST PHARMACEUTICALS, INC. |
02/14/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/14/2020 |
SC 13G/A
| BAKER BROS. ADVISORS LP reports a 10% stake in BioCryst Pharmaceuticals, Inc. |
02/13/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/13/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/12/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/05/2020 |
SC 13G/A
| BlackRock Inc. reports a 7.9% stake in BIOCRYST PHARMACEUTICALS INC |
01/22/2020 |
SC 13G/A
| INTEGRATED CORE STRATEGIES LLC reports a 6.5% stake in BIOCRYST PHARMACEUTICALS, INC. |
02/14/2019 |
SC 13G/A
| RA CAPITAL MANAGEMENT, LLC reports a 9.7% stake in BIOCRYST PHARMACEUTICALS, INC. |
02/13/2019 |
SC 13G/A
| BAKER BROS. ADVISORS LP reports a 13.8% stake in BioCryst Pharmaceuticals, Inc. |
02/12/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/11/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/11/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/04/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
08/06/2018 |
SC 13G/A
| RA CAPITAL MANAGEMENT, LLC reports a 8.5% stake in BIOCRYST PHARMACEUTICALS, INC. |
07/10/2018 |
SC 13G/A
| HENDERSON GROUP PLC reports a 11.2% stake in BIOCRYST PHARMACEUTICALS, INC. |
02/14/2018 |
SC 13G/A
| RTW INVESTMENTS, LLC reports a 3.4% stake in BioCryst Pharmaceuticals, Inc. |
02/14/2018 |
SC 13G/A
| Flynn James E reports a 7.3% stake in BioCryst Pharmaceuticals, Inc. |
|
|
|